Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter Clinical Study on the Efficacy and Safety of PD-1 Inhibitors Combined With Venetoclax+CAG Regimens in the Treatment of Adult Refractory/Relapsed Acute T-lymphoblastic Leukemia (T-ALL)
Conditions
Interventions
PD-1 Inhibitors
Locations
1
China
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Start Date
May 1, 2025
Primary Completion Date
January 31, 2027
Completion Date
January 31, 2029
Last Updated
April 21, 2026
Lead Sponsor
Fujian Medical University Union Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions